Member Info for JRDC

FFS
Directors talk, without the space

The obfuscated link is *************

This link popped up on Chrome for me, isn't dated but assume recent. Apologies if already posted

https://www.*************.net/avacta-group-qa-a-really-excellent-period-of-growth-lonavct/

So in order of news, I'm predicting

Ava6000, CTA by end October
Antigen lfd clinical validation - mid November, expected to start shipments in Jan 2021 will coincide with l Novacyt contract expiry, may extend novas contract until production ramped up sufficiently. Consumer self use and scaled production in Q2 2021.
Further partnership announcements re. Diagnostics - Nov-Dec, Q1 2021
ISO 13485 - End November

Maybe some other jam too, but they're the key ones mentioned (with my estimate)
Not expecting anything explosive to the SP until November, perhaps a slow rise as investers start to jump on the wagon.

They're targeting poorer countries, the ones would who pay cost price at best for our tests so the market has no value for us. Western markets are the main focus.

Agree. Every spare penny I have is pretty much split between here with avr 1.40 and novacyt avr £3.70.

Next 3 months are going to be spectacular, I missed out on bitcoin in the early days, I'm not missing it this time.

Superb post. I think as vaccine trials are postponed, or news that extreme reactions are possible, or it isn't fully effective and never will be, nova will soar. The antibody test will be key, especially to elderly and vulnerable who have been vaccinated and want to ensure they're protected to some degree. I think when investors cotton on to this, and the fact it could will be here forever, much like flu, means we're merely at the start of company growth. Who knows, maybe one day we'll be buying out GSK!

At the very least hold for the next 14 weeks, if 2nd part of contract kicks in that doubles the SP alone!

Let's hope it goes better than skins.

FFS freeeeeeeetraaaaade dot io

Just a heads up that Ncyt (amongst others) are now available on ************

You'll need their plus account which is £10 a month (includes an ISA account too which is a£3 a month normally), you can set buy/sell prices too. Trades are free, hence the name, and executed immediately (used to be once a day)

Have been using them for about a year, CS is good and the Devs respond to questions on the forum. They're a lot better than interactive investor, put it that way!

Open an isa account and you'll get a £15 share too

https://************/

Must admit, I wasn't expecting to see £5 before Xmas, but when potential competitors like SKIN **** up so badly, its amazing nearly 10 months in to the pandemic and we're about the only AIM covid share making serious money, and others are still months away from an income.

Actually ken, PCR can be used on saliva too, ncyt have a test currently on the market from July compatible with existing machines and require little change to work flow. Not deramping, just correcting an inaccuracy.

@PL45 - because the only people who can distribute (not necessarily just sell) are medusa. If there are clauses to allow public bodies to distribute we'll probably never know unless the contract is made public. I doubt it though, as although the medusa lot are cowboys I think they'll know that if they govt were able to distrbute to the public for free then there goes their business. (Was tempted to write their goes there business). If the govt could supply fruit and veg free to the general public, would you setup a shop selling fruit and veg?

Also forgot to add to comment below, their antibody tests are sold in lots of 25 but you only get a single 3ml buffer solution - this is to prevent people then reselling directly to the public, and you cannot buy their solution separately. I imagine it will be the same with the antigen test, buy in boxes of 25/50 but unable to split down.

I enquired about their antigen test on Monday (I've ordered a shipment of their antibody tests), they're not part of the condor program, they're working with university of Birmingham. Swab must be taken by a clinically trained professional, definitely not for self testing at home. They don't have numbers on the tests accuracy yet, still being validated but will send me some info in November as well as prices. For now they may well be after the same markets as avacta, eg in care setting, perhaps sporting events, but I don't see them even being made available for home use. I think Avacta have a huge advantage next year if they're allowed to sell to end consumer directly. Just a shame the UK Govt won't be allowed to purchase the tests and distribute themselves, but thats the fault of whichever twat signed the exclusivity contract with medusa.

'Avacta have done their bit its now out of their hands.'

I sincerely hope not. Thats like final day of footie season, your team has won but you're hoping other results go your way to stay up, not a good place to be.

FFS, that means we'll be relying on Medusa as per our contract. Whoever signed that contract off for exclusive distribution rights needs a slap. That better not be the reason we haven't released anything yet.

Many covid shares Inc Avacta are tanking, annoyingly, ncyt doing ok. Wonder if the fact we're the only ones making money is to do with it. Fantastic share to own right now!

True, phantom. But with current regulations it's also true that currently Avacta spit test results will need to be interpreted by a clinical practice professional too. Not a single covid test, antibody or antigen, has been authorised for self use so at some point early next year the regulations will have to change in time for Boris Spring aim. This will be the biggest hurdle Avacta and any spit stick testing company faces, and probably why clinical validation and trials are taking so long, they need to make sure the test can be interpreted correctly by the general public. After all, nearly 50% of people are stupider than average.

The UK govt wasn't interested in their antibody test, despite being one of the first to market, majority of their sales are from abroad.

Got 50 of surescreens antibody tests arriving in the next week or so, will be interesting to see the quality of them, will enquire about the antigen too, how it works, are they aiming for self administration etc. The fact there's a 2nd more accurate (and no doubt more expensive) test would leave me to conclude it's some way behind the accuracy of affimers.

People taking profit, and why not, many of them will have bought back in when it crashed to £2.20 or invested when it was pennies so have made a lovely life changing profit. Must admit I was very tempted to sell the rest of my at £4 this morning, its the price I said I thought it would hit a few weeks back on results RNS. Might see what other news is released later in the month wrt France, possible tender/tie ups, maybe we'll edge towards £4.50. Nova expecting current sales to last in to first half of next year, suppose people asking where 2nd half of 2021 and 2022 revenues are going to come from, GM looking in to other potential aquisitions, which is why imo we're probably close to peaking. Been a lovely run though, unless you went all in at £5.

Fantastic, everyone here should now be showing a nice green. Well done all!